BACKGROUND: Cortisol is presumed to be a risk factor for stress- and age-related disorders, such as depressive disorder and Alzheimer's disease (AD). The aim of this study was to investigate the association of plasma cortisol concentration with AD in presence or absence of comorbid depressive symptoms. MATERIAL AND METHODS: Plasma cortisol concentration was measured in 80 AD patients (35 of them with depressive symptoms), 27 elderly depressive patients without AD, and 37 elderly controls. RESULTS: Compared to controls, a significant increase of mean plasma cortisol was found in AD patients but not in depressive patients. Plasma cortisol was positively correlated with cognitive impairment in AD patients. We confirmed a U-shaped association between plasma cortisol and major depression and a linear association between plasma cortisol and AD without depressive symptoms. Significantly increased relative risk of disease in people with high plasma cortisol was found for AD with depressive symptoms and for AD with mild dementia. CONCLUSIONS: Plasma cortisol reflects the degree of cognitive impairment in AD rather than the severity of comorbid depression. We confirmed that both hypercortisolemia and hypocortisolemia are associated with depressive disorder. Significant association between high plasma cortisol and AD was found, supporting the use of high plasma cortisol as a component of a panel of biochemical markers for AD with depressive symptoms as well as AD in the early stage of dementia development.

Department of Psychiatry 1st Faculty of Medicine Charles University Prague and General University Hospital Prague Prague Czech Republic

Zobrazit více v PubMed

Migliorelli R, Tesón A, Sabe L, et al. Prevalence and correlates of dysthymia and major depression among patients with Alzheimer’s disease. Am J Psychiatry. 1995;152:37–44. PubMed

Lyketsos CG, Olin J. Depression in Alzheimer‘s disease: overview and treatment. Biol Psychiatry. 2002;52:243–52. PubMed

Starkstein SE, Jorge R, Mizrahi R, Robinson RG. The construct of minor and major depression in Alzheimer‘s disease. Am J Psychiatry. 2005;162:2086–93. PubMed

Lyketsos CG, Carrillo MC, Ryan JM, et al. Neuropsychiatric symptoms in Alzheimer‘s disease. Alzheimers Dement. 2011;7:532–39. PubMed PMC

Sierksma AS, van den Hove DL, Steinbusch HW, Prickaerts J. Major depression, cognitive dysfunction and Alzheimer’s disease: is there a link? Eur J Pharmacol. 2010;626:72–82. PubMed

Ricci S, Fuso A, Ippoliti F, Businaro R. Stress-induced cytokines and neuronal dysfunction in Alzheimer’s disease. J Alzheimers Dis. 2012;28:11–24. PubMed

Schmidt HD, Shelton RC, Duman RS. Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology. 2011;36:2375–94. PubMed PMC

Maes M, Fišar Z, Medina M, et al. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates – Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology. 2012;20:127–50. PubMed

Bao AM, Meynen G, Swaab DF. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev. 2008;57:531–53. PubMed

Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs. low CRH/NE states. Mol Psychiatry. 2002;7:254–75. PubMed

Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J Affect Disord. 2001;62:77–91. PubMed

Otte C, Hart S, Neylan TC, et al. A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology. 2005;30:80–91. PubMed

Van Cauter E, Leproult R, Kupfer DJ. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab. 1996;81:2468–73. PubMed

Laughlin GA, Barrett-Connor E. Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study. J Clin Endocrinol Metab. 2000;85:3561–68. PubMed

Halbreich U, Asnis GM, Zumoff B, et al. Effect of age and sex on cortisol secretion in depressives and normals. Psychiatry Res. 1984;13:221–29. PubMed

Gotthardt U, Schweiger U, Fahrenberg J, et al. Cortisol, ACTH, and cardiovascular response to a cognitive challenge paradigm in aging and depression. Am J Physiol. 1995;268:R865–73. PubMed

O’Brien JT, Lloyd A, McKeith I, et al. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry. 2004;161:2081–90. PubMed

Hinkelmann K, Moritz S, Botzenhardt J, et al. Cognitive impairment in major depression: association with salivary cortisol. Biol Psychiatry. 2009;66:879–85. PubMed

Köhler S, Thomas AJ, Lloyd A, et al. White matter hyperintensities, cortisol levels, brain atrophy and continuing cognitive deficits in late-life depression. Br J Psychiatry. 2010;196:143–49. PubMed

ó Hartaigh B, Loerbroks A, Thomas GN, et al. Age-dependent and -independent associations between depression, anxiety, DHEAS, and cortisol: from the MIPH Industrial Cohort Studies (MICS) Psychoneuroendocrinology. 2012;37:929–36. PubMed

Oldehinkel AJ, van den Berg MD, Flentge F, et al. Urinary free cortisol excretion in elderly persons with minor and major depression. Psychiatry Res. 2001;104:39–47. PubMed

Bremmer MA, Deeg DJ, Beekman AT, et al. Major depression in late life is associated with both hypo- and hypercortisolemia. Biol Psychiatry. 2007;62:479–86. PubMed

Rimmele U, Besedovsky L, Lange T, Born J. Blocking mineralocorticoid receptors impairs, blocking glucocorticoid receptors enhances memory retrieval in humans. Neuropsychopharmacology. 2013;38:884–94. PubMed PMC

Schilling TM, Kölsch M, Larra MF, et al. For whom the bell (curve) tolls: Cortisol rapidly affects memory retrieval by an inverted U-shaped dose-response relationship. Psychoneuroendocrinology. 2013 S0306-4530(13)00005-X. PubMed

Bob P, Fedor-Freybergh P, Jasova D, et al. Dissociative symptoms and neuroendocrine dysregulation in depression. Med Sci Monit. 2008;14(10):CR499–504. PubMed

Fjell AM, Walhovd KB. Neuroimaging results impose new views on Alzheimer’s disease – the role of amyloid revised. Mol Neurobiol. 2012;45:153–72. PubMed

Zimny A, Bladowska J, Neska M, et al. Quantitative MR evaluation of atrophy, as well as perfusion and diffusion alterations within hippocampi in patients with Alzheimer’s disease and mild cognitive impairment. Med Sci Monit. 2013;19:86–94. PubMed PMC

Swaab DF, Bao AM, Lucassen PJ. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev. 2005;4:141–94. PubMed

Umegaki H, Ikari H, Nakahata H, et al. Plasma cortisol levels in elderly female subjects with Alzheimer’s disease: a cross-sectional and longitudinal study. Brain Res. 2000;881:241–43. PubMed

Weiner MF, Vobach S, Olsson K, et al. Cortisol secretion and Alzheimer’s disease progression. Biol Psychiatry. 1997;42:1030–38. PubMed

Comijs HC, Gerritsen L, Penninx BW, et al. The association between serum cortisol and cognitive decline in older persons. Am J Geriatr Psychiatry. 2010;18:42–50. PubMed

Huang CW, Lui CC, Chang WN, et al. Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer’s disease. J Clin Neurosci. 2009;16:1283–86. PubMed

Davis KL, Davis BM, Greenwald BS, et al. Cortisol and Alzheimer’s disease, I: Basal studies. Am J Psychiatry. 1986;143:300–5. PubMed

Csernansky JG, Dong H, Fagan AM, et al. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. Am J Psychiatry. 2006;163:2164–69. PubMed PMC

Schrijvers EM, Direk N, Koudstaal PJ, et al. Associations of serum cortisol with cognitive function and dementia: the Rotterdam Study. J Alzheimers Dis. 2011;25:671–77. PubMed

Gil-Bea FJ, Aisa B, Solomon A, et al. HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer’s disease. J Alzheimers Dis. 2010;22:829–38. PubMed

Tanaka M, Ishii A, Yamano E, et al. Effect of a human-type communication robot on cognitive function in elderly women living alone. Med Sci Monit. 2012;18(9):CR550–57. PubMed PMC

Doecke JD, Laws SM, Faux NG, et al. Alzheimer’s Disease Neuroimaging Initiative; Australian Imaging Biomarker and Lifestyle Research Group: Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol. 2012;69:1318–25. PubMed PMC

Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol. 2011;7:323–31. PubMed PMC

Tanaka M, Ishii A, Yamano E, et al. Cognitive dysfunction in elderly females with depressive symptoms. Med Sci Monit. 2012;18(12):CR706–11. PubMed PMC

Greenwald BS, Kramer-Ginsberg E, Marin DB, et al. Dementia with coexistent major depression. Am J Psychiatry. 1989;146:1472–78. PubMed

Ownby RL, Crocco E, Acevedo A, et al. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry. 2006;63:530–58. PubMed PMC

Lee HB, Lyketsos CG. Depression in Alzheimer’s disease: heterogeneity and related issues. Biol Psychiatry. 2003;54:353–62. PubMed

Meynen G, Unmehopa UA, Hofman MA, et al. Hypothalamic vasopressin and oxytocin mRNA expression in relation to depressive state in Alzheimer’s disease: a difference with major depressive disorder. J Neuroendocrinol. 2009;21:722–29. PubMed

Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 17:1982–1983. 37–49. PubMed

Hirschfeld RM. Screening for bipolar disorder. Am J Manag Care. 2007;13:S164–69. PubMed

Carroll BJ, Iranmanesh A, Keenan DM, et al. Pathophysiology of hypercortisolism in depression: pituitary and adrenal responses to low glucocorticoid feedback. Acta Psychiatr Scand. 2012;125:478–91. PubMed PMC

Bélanger A, Candas B, Dupont A, et al. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J Clin Endocrinol Metab. 1994;79:1086–90. PubMed

Schüle C. Neuroendocrinological mechanisms of actions of antidepressant drugs. J Neuroendocrinol. 2007;19:213–26. PubMed

Laske C, Stransky E, Fritsche A, et al. Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Aβ 1-42 ratios in CSF in patients with mild Alzheimer’s disease dementia. Eur Arch Psychiatry Clin Neurosci. 2009;259:80–85. PubMed

Kumsta R, Entringer S, Hellhammer DH, Wüst S. Cortisol and ACTH responses to psychosocial stress are modulated by corticosteroid binding globulin levels. Psychoneuroendocrinology. 2007;32:1153–57. PubMed

Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer's Disease and Identifying Promising Drug Targets

Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder